| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 09/20/2006 | EP0889889B1 Piperazine and piperidine compounds |
| 09/20/2006 | CN1835923A Process for preparation of 4-amino-3-quinolinecarbonitriles |
| 09/20/2006 | CN1835914A New benzamides as PPAR[upsilon] modulators |
| 09/19/2006 | US7109341 Antitumor agents; such as 2-(4-((7-Bromo-2-quinolinyl)oxy)phenoxy)propionmethylamide |
| 09/19/2006 | US7109338 For use in the prophylaxis and the treatment of Picornavirus and human rotavirus infections. |
| 09/19/2006 | US7109224 Acyl guanidine compounds and use thereof |
| 09/19/2006 | US7109213 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them |
| 09/19/2006 | US7109212 Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| 09/19/2006 | US7109211 Treating arthritis, pain and cancer; cyclooxygenase-2 inhibitors |
| 09/14/2006 | WO2006094843A1 Piperazine derivatives as glyt1 inhibitors |
| 09/14/2006 | US20060205794 e.g. 4-{(1R)-2-[(6-{4-[3-(Cyclopentylsulfinyl)phenyl]butoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol; beta 2-adrenoreceptor agonist; asthma, chronic obstructive pulmanory disease, bronchitis; antidepressant |
| 09/14/2006 | US20060205773 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 09/14/2006 | US20060205772 Amide derivatives and their use as inhibitors of 11-beta-hydroxysteroid dehydrogenase type I |
| 09/14/2006 | US20060205734 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/14/2006 | US20060205712 e.g. N-[2-[4-(2-(S)-amino-6-dimethylamino-hexanoyl)-piperazin-1-yl]-1,1-dimethyl-2-oxo-ethyl]-2,4-dichloro-3-(2-methyl -quinolin-8-yloxy-methyl)-benzensulfonamide trifluoroacetate; antiinflammatory agent; asthma, chronic bronchitis, allergic rhinitis, obstructive pulmonary disease (COPD) |
| 09/14/2006 | US20060204785 Dopant iridium complexes of 2-alkylphenylquinolines and an alkanedione; dopant of the light emitting layer; host compounds are aluminum or zinc complexes; high color purity, high brightness, and long durability; flat panel displays |
| 09/14/2006 | US20060204577 Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1832924A Aluminum chelate complex for organic el material |
| 09/13/2006 | CN1830964A 4-Substituting anilino-3-nitroquinoline compounds, prepn. method and use thereof |
| 09/13/2006 | CN1274676C Quinoline and quinazoline derivatives |
| 09/13/2006 | CN1274670C Diaminopropionic acid derivatives |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105531 Tricyclic protein kinase inhibitors |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | CA2241788C Novel n-(arylsulphonyl)amino acid derivatives, their preparation process and pharmaceutical compositions containing them |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/08/2006 | WO2006094237A2 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093336A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093253A1 Novel cyclic compound having quinolylalkylthio group |
| 09/08/2006 | WO2006067414A3 Glycine transport inhibitors |
| 09/08/2006 | WO2005094374A3 Hydrazide-containing cftr inhibitor compounds and uses thereof |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599992A1 Acridine and quinoline dervatives as sirtuin modulators |
| 09/07/2006 | US20060199840 Chemical derivatives and their application as antitelomerase agent |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/06/2006 | EP1698623A1 Crystal of salt of 4-(3-chloro-4-(cyclopropylaminocarbonyl)amino-phenoxy)-7-methoxy-6-quinolinecarboxamide or of solvate thereof and processes for producing these |
| 09/06/2006 | EP1698618A1 Benzamide derivative |
| 09/06/2006 | EP1697337A2 Ornithine derivatives as prostaglandin-e2-agonists or antagonists |
| 09/06/2006 | EP1697326A1 Crystal form of quinoline compound and process for its production |
| 09/06/2006 | EP1696924A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1501802B1 Process for the preparation of quinoline derivatives |
| 09/06/2006 | CN1829718A Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 09/06/2006 | CN1829695A Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/06/2006 | CN1829694A Quinoline derivates and their use in therapy |
| 09/06/2006 | CN1829693A Therapeutic agent for chronic obstructive pulmonary disease and method for treatment for chronic obstructive pulmonary disease with the same |
| 09/06/2006 | CN1273452C 7-(4,4-dimethyl-3-aminomethylpentazane-1-yl) substituted quinoline carboxylic acid derivative and its preparation |
| 09/06/2006 | CN1273444C Dipeptide nitriles |
| 09/06/2006 | CN1273128C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides |
| 09/05/2006 | US7102008 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme |
| 09/05/2006 | US7102007 Dihydroindole and tetrahydroquinoline derivatives |
| 09/05/2006 | US7102000 Heterocyclic amide derivatives for the treatment of diabetes and other diseases |
| 09/05/2006 | US7101915 P-terphenyl compounds |
| 09/05/2006 | US7101907 Topical administration of statins for treatment of bone disorders |
| 09/05/2006 | US7101533 Agent for inducing receptor potential |
| 08/31/2006 | WO2006091769A1 Novel quinoline derivatives as potassium ion channel openers |
| 08/31/2006 | WO2006091674A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/31/2006 | WO2006090932A1 Surrogate marker for sulfonamide compound |
| 08/31/2006 | WO2006089689A1 2-quinolone compounds as inhibitors of phosphodiesterases |
| 08/31/2006 | WO2006074025B1 Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolase |
| 08/31/2006 | US20060194839 Process for the preparation of Montelukast |
| 08/31/2006 | US20060194838 Polymorphic form of montelukast sodium |
| 08/31/2006 | US20060194818 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194805 Capsaicin receptor agonists |
| 08/31/2006 | US20060194798 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 08/31/2006 | US20060194793 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 08/31/2006 | US20060194792 1-Cyclic carbonyl-4-(4-quinoline-)-1,4-diazepine or 1-cyclic carbonyl-4-[4-(1H-quinolin-2-{thio}one)-1,4-diazepinone derivatives; retinopathy, adult respiratory distress syndrome, asthma, osteoarthritis, glomerulonephritis, psoriasis, rheumatoid arthritis, and toxic shock syndrome treatment |
| 08/31/2006 | US20060193780 cyanine dyes and/or with lipophilic side chains; to detect stained cells both in vivo and in vitro; increased signal to noise ratio for rapidly labeling; improved solubility |
| 08/31/2006 | CA2599151A1 Novel quinoline derivatives as potassium ion channel openers |
| 08/31/2006 | CA2598133A1 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 08/30/2006 | EP1695964A1 Quinoline derivatives for use as intermediates in the synthesis of heterocyclylalcoyl piperidines |
| 08/30/2006 | EP1694689A1 Monocyclopentadienyl complexes |
| 08/30/2006 | EP1694653A1 Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(adp-ribose) polymerase inhibitors |
| 08/30/2006 | EP1694640A1 Anti-cancer agents |
| 08/30/2006 | EP1694329A2 Diamine and iminodiacetic acid hydroxamic acid derivates |
| 08/30/2006 | EP1694327A2 Novel m3 muscarinic acetylcholine receptor antagonists |
| 08/30/2006 | EP1368389B1 Complexed compounds and use thereof for the polymerisation of olefins |
| 08/30/2006 | EP0994100B1 3-anilino-2-cycloalkenone derivates |
| 08/30/2006 | CN1826321A Quinolone derivative or its salt |
| 08/30/2006 | CN1826314A Method for production of dollar g(a), dollar g(b)-unsaturated amide compounds |
| 08/30/2006 | CN1272323C Prepn of quinolone carboxylate |
| 08/30/2006 | CN1272322C Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
| 08/30/2006 | CN1272313C 20-hydroxyeicosatetraenoic acid production inhibitors |
| 08/30/2006 | CN1272105C Catalysts comprising N-substituted cyclic imides and processes for preparing organic compounds with catalysts |
| 08/29/2006 | US7098340 Quinoline/chromene derivatives as androgen antagonist |
| 08/29/2006 | US7098226 E.g., 1-(2-(1-adamantyl)ethyl)-1-pentyl-3-(3-(4-pyridyl)propyl)urea; useful as therapeutic agents for autoimmune diseases such as rheumatoid arthritis. |
| 08/29/2006 | US7098222 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents |
| 08/29/2006 | US7098219 Inhibitors of cellular efflux pumps of microbes |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | CA2212856C Benzopyran-containing compounds and method for their use |
| 08/29/2006 | CA2158746C Process for preparing 6-fluoro-2-haloquinoline |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/24/2006 | WO2006034491A3 Phenyl-substituted quinoline and quinazoline compounds for the treatment of diabetes |
| 08/24/2006 | WO2005004810A3 Arylsulfonamide derivatives |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189809 Method for the synthesis of quinoline derivatives |
| 08/24/2006 | US20060189804 Synthetic method for the preparation of quinazolin-4-one derivative |